HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Luiz Felipe Forgiarini Selected Research

Reperfusion Injury

12/2014N-acetylcysteine administration confers lung protection in different phases of lung ischaemia-reperfusion injury.
8/2013Endobronchial perfluorocarbon administration decreases lung injury in an experimental model of ischemia and reperfusion.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Luiz Felipe Forgiarini Research Topics

Disease

5Hypoxia (Hypoxemia)
03/2015 - 01/2012
4Sleep Apnea Syndromes (Sleep Apnea)
01/2015 - 01/2012
3Inflammation (Inflammations)
01/2018 - 01/2012
2Necrosis
01/2018 - 12/2014
2Reperfusion Injury
12/2014 - 08/2013
2Brain Death (Brain Dead)
02/2014 - 03/2013
2Alcoholic Fatty Liver
06/2013 - 01/2011
1Obstructive Sleep Apnea
03/2015
1Hypoadiponectinemia
09/2014
1Hemorrhage
02/2014
1Carotid Artery Diseases
02/2014
1Atherosclerosis
02/2014
1Lung Injury
08/2013
1Ischemia
08/2013
1Brain Edema (Cerebral Edema)
01/2013
1Central Sleep Apnea (Central Sleep Apnea Syndrome)
01/2012
1Non-alcoholic Fatty Liver Disease
01/2012
1Fibrosis (Cirrhosis)
01/2012
1Weight Loss (Weight Reduction)
01/2011
1Fatty Liver
01/2011
1Exsanguination
01/2011
1Diabetes Mellitus
07/2010
1Experimental Diabetes Mellitus
07/2010

Drug/Important Bio-Agent (IBA)

5salicylhydroxamic acid (SHAM)IBA
03/2015 - 01/2013
3AntioxidantsIBA
01/2015 - 01/2011
2Messenger RNA (mRNA)IBA
03/2015 - 09/2014
2LipidsIBA
03/2015 - 02/2014
2Oxygen (Dioxygen)IBA
03/2015 - 01/2013
2Acetylcysteine (Siran)FDA LinkGeneric
01/2015 - 12/2014
2NF-kappa B (NF-kB)IBA
12/2014 - 01/2012
2Caspase 3 (Caspase-3)IBA
12/2014 - 01/2012
2Thiobarbituric Acid Reactive SubstancesIBA
12/2014 - 07/2010
2MethylprednisoloneFDA LinkGeneric
02/2014 - 03/2013
2Choline (Choline Chloride)IBA
06/2013 - 01/2011
2Methionine (L-Methionine)FDA Link
06/2013 - 01/2011
1C-Reactive ProteinIBA
01/2018
1Interleukin-10 (Interleukin 10)IBA
01/2018
1Interleukin-8 (Interleukin 8)IBA
01/2018
1Interleukin-6 (Interleukin 6)IBA
01/2018
1InterleukinsIBA
01/2018
1Uncoupling Protein 2IBA
03/2015
1Insulin (Novolin)FDA Link
03/2015
1MelatoninIBA
01/2015
1Proteins (Proteins, Gene)FDA Link
01/2015
1Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
12/2014
1Superoxide DismutaseIBA
12/2014
1Interleukin-1beta (Interleukin 1 beta)IBA
12/2014
13-nitrotyrosineIBA
12/2014
1Peroxidase (Myeloperoxidase)IBA
12/2014
1AdiponectinIBA
09/2014
1C.I. direct red 80IBA
02/2014
1Saline SolutionIBA
02/2014
1CollagenIBA
02/2014
1Pharmaceutical PreparationsIBA
02/2014
1Eosine Yellowish-(YS) (Eosin)IBA
02/2014
1Hematoxylin (Haematoxylon)IBA
02/2014
1Matrix Metalloproteinases (MMPs)IBA
02/2014
1FluorocarbonsIBA
08/2013
1QuercetinIBA
06/2013
1FlavonoidsIBA
06/2013
1Membrane Proteins (Integral Membrane Proteins)IBA
01/2013
1Aquaporins (Water Channels)IBA
01/2013
1Nitric Oxide Synthase (NO Synthase)IBA
01/2012
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2012
1NoxaeIBA
01/2012
1Carbon Tetrachloride (Tetrachloromethane)IBA
01/2012
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2012
1Free RadicalsIBA
01/2012
1Transcription Factors (Transcription Factor)IBA
01/2012
1HDL CholesterolIBA
01/2011
1Triglycerides (Triacylglycerol)IBA
01/2011
1EnzymesIBA
01/2011
1pimagedine (aminoguanidine)IBA
07/2010
1GasesIBA
07/2010

Therapy/Procedure

1Artificial Respiration (Mechanical Ventilation)
01/2018
1Transplantation
02/2014
1Catheters
03/2013
1Laparotomy
01/2011
1Hepatectomy
01/2011